Collegium PharmaceuticalvsEli Lilly and Company

COLL and LLY stock compared: price, dividend, valuation and results, from SEC filings.

COLL

Collegium Pharmaceutical, Inc.

$25.32

Value $804M

+1.48%
COLL's page

LLY

Eli Lilly and Company

$1,443.50

Value $1.36T

+1.14%
LLY's page

Collegium Pharmaceutical (COLL) has a market value of $804M and Eli Lilly and Company (LLY) $1.36T. Over the last year, with dividends, COLL moved -46.5% and LLY +42.9%. The P/E is 21.1 for COLL and 49.4 for LLY. Dividend yield: COLL none, LLY 0.44%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    COLL$804M

    LLY$1.36T

    LLY is 1,694 times COLL

  • Revenue, 12 months

    COLL$815M

    LLY$86.5B

    LLY is 106 times COLL

  • Net income, 12 months

    COLL$38M

    LLY$27.6B

    LLY is 723 times COLL

  • Operating margin

    COLL15.2%

    LLY–

  • ROIC

    COLL19.2%

    LLY35.5%

    16.3 points apart

  • P/E

    COLL21.1

    LLY49.4

    LLY is 2.3 times COLL

  • Dividend yield

    COLL0.0%

    LLY0.4%

    0.4 points apart

  • 5-year return

    COLL+30.0%

    LLY+480.4%

    450.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

COLL+30.0%

LLY+480.5%

20040060020222023202420252026
Returns by period
PeriodCOLLWith dividendsLLYWith dividends
1 year since November 12, 2025-46.5%Price -46.5%+42.9%Price +41.8%
3 years since November 13, 2023+0.5%+0.2% a yearPrice +0.5%+140.8%+34.0% a yearPrice +135.6%
5 years since November 12, 2021+30.0%+5.4% a yearPrice +30.0%+480.4%+42.2% a yearPrice +455.9%
10 years since November 15, 2016+53.3%+4.4% a yearPrice +53.3%+2,071.6%+36.0% a yearPrice +1,766.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

COLLCollegium PharmaceuticalLLYEli Lilly and Company

Valuation

COLLLLY
Valuation
Price$25.32$1,443.50
Market value$804M$1.36T
Enterprise value (EV)–$1.41T
P/E21.149.4
P/E, 5-year median19.649.9
P/B2.733.8
EV/EBIT–40.5
Free cash flow yield41.8%1.4%

Results and growth

COLLLLY
Results and growth
Revenue, 12 months$815M$86.5B
Net income, 12 months$38M$27.6B
Free cash flow, 12 months$336M$19.7B
Earnings per share, 12 months$1.20$30.81
Revenue growth, year on year23.6%44.7%
Revenue growth a year, past+20.3%over 5 years+21.6%over 5 years
EPS growth a year, past+17.9%over 5 years+27.6%over 5 years

Margins and returns on capital

COLLLLY
Margins and returns on capital
Gross margin59.1%83.6%
Operating margin15.2%–
Net margin4.7%31.9%
ROIC19.2%35.5%
ROE12.8%88.6%

Balance sheet

COLLLLY
Balance sheet
Cash$145M$4.9B
Total debt–$49.5B
Net debt / EBITDA–1.2
Interest cover1.6×38.9×

Dividends and buybacks

COLLLLY
Dividends and buybacks
Dividend yield–0.4%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield3.1%0.3%
Shareholder yield3.1%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: COLL or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Collegium Pharmaceutical or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.36T) is about 1,693.7 times Collegium Pharmaceutical ($804M), at today's prices.

How did COLL and LLY stock do over the last 10 years?

Since November 15, 2016, COLL's price moved +53.3% and LLY's +1,766.9%. With dividends: COLL +53.3% (+4.4% a year), LLY +2,071.6% (+36.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, COLL or LLY?

The dividend yield at today's price is none for Collegium Pharmaceutical and 0.44% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

What is the P/E of COLL and LLY?

At today's price, the P/E is 21.1 for COLL and 49.4 for LLY. The median of the last five years was 19.6 and 49.9, which shows where each stands against its own past.

Which has the higher profit margins, Collegium Pharmaceutical or Eli Lilly and Company?

Over the last twelve months, the net margin was 4.7% for Collegium Pharmaceutical and 31.9% for Eli Lilly and Company, and the operating margin 15.2% and –. Revenue was $815M and $86.5B.

Which is the better investment, Collegium Pharmaceutical or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.